Basmayor, Clarence S.

HRN: 27-61-11  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/10/2025
08/16/2025
IV
220 Mg
Q8
Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: